Informations générales (source: ClinicalTrials.gov)
Adult-onset Generalized Morphea : A Retrospective Multicenter Study (MORPHEA)
Observational
University Hospital, Strasbourg, France (Voir sur ClinicalTrials)
décembre 2019
avril 2020
29 juin 2024
This study aimed to describe the demographical and clinical characteristics of a
retrospective cohort of adult-onset GM and to investigate whether these findings differ
between patients with an isomorphic and a symmetric pattern of lesion distribution.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Service de dermatologie - Hôpital Civil de Strasbourg - 67091 - Strasbourg - France | Cédric LENORMAND, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Age of onset ≥ 18 years
- Patients with generalized morphea as defined by criteria established by Laxer and
Zulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency
to confluence and involve at least 2 different anatomic sites)
- Availability of good-quality clinical photographs
- Patient who, after being informed, has not expressed his or her opposition to the
re-use of his or her data for the purposes of this research
- Age of onset ≥ 18 years
- Patients with generalized morphea as defined by criteria established by Laxer and
Zulian (4 or more morpheaform plaques larger than 3 centimeters that show tendency
to confluence and involve at least 2 different anatomic sites)
- Availability of good-quality clinical photographs
- Patient who, after being informed, has not expressed his or her opposition to the
re-use of his or her data for the purposes of this research
- Patients with linear morphea who met criteria for generalized morphea
- Patient's opposition to participate